Mable

Mable, operating under the legal name Neurolytic Healthcare, Inc., is a health tech company founded in 2019 and headquartered in California. The company specializes in genomics-based telehealth services, focusing on the personalized care of migraine sufferers. Mable's platform combines genetic and biomarker data to create tailored healthcare plans, aiming to improve the treatment and management of migraines, a complex neurological condition affecting millions worldwide. By using genomics, Mable seeks to enhance the understanding of individual patients' predispositions to migraines and their re…